Literature DB >> 8187430

Ankylosing spondylitis associated with osteoporosis and vertebral deformity.

T W 'Neill1, P Prouse, A K Bhalla.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8187430     DOI: 10.1007/bf02229877

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

1.  Osteoporosis in ankylosing spondylitis.

Authors:  H M Rubinstein
Journal:  Br J Rheumatol       Date:  1991-04

2.  Psoriatic spondylitis presenting as chronic torticollis.

Authors:  F Witham; P L Williams
Journal:  Br J Rheumatol       Date:  1991-12

3.  Osteoporosis and ankylosing spondylitis.

Authors:  A Calin
Journal:  Br J Rheumatol       Date:  1991-08

4.  Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis.

Authors:  S H Ralston; G D Urquhart; M Brzeski; R D Sturrock
Journal:  BMJ       Date:  1990-03-03

5.  Osteoporosis in early ankylosing spondylitis: a primary pathological event?

Authors:  R Will; R Palmer; A K Bhalla; F Ring; A Calin
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

6.  Bone mass in ankylosing spondylitis.

Authors:  D M Reid; J J Nicoll; N S Kennedy; M A Smith; P Tothill; G Nuki
Journal:  J Rheumatol       Date:  1986-10       Impact factor: 4.666

7.  Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27.

Authors:  D G Spencer; W M Park; H M Dick; S N Papazoglou; W W Buchanan
Journal:  J Rheumatol       Date:  1979 May-Jun       Impact factor: 4.666

8.  Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis.

Authors:  H Franck; E Keck
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

  8 in total
  1 in total

Review 1.  High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.

Authors:  M A C van der Weijden; T A M Claushuis; T Nazari; W F Lems; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Clin Rheumatol       Date:  2012-06-16       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.